• 1. A comparative study of lysosome-targetable pH probes based on phenoxazinium attached with aliphatic and aromatic amines
  Xiu-Li Wang,Xiao-Jun Li,Ru Sun,Yu-Jie Xu,Jian-Feng Ge Analyst 2016 141 2962
• 2. 752. The Ehrlich–Sachs reaction. Part II
  D. M. W. Anderson,F. Bell J. Chem. Soc. 1959 3708
• 3. Cytotoxic compounds. Part XVII. o-, m-, and p-(Bis-2-chloroethylamino)phenol, p-[N-(2-chloroethyl)methylamino]phenol, NN-bis-2-chloroethyl-p-phenylenediamine, and NN-bis-2-chloroethyl-N′-methyl-p-phenylenediamine as sources of biologically active carbamates
  Peter D. Edwards,Duncan L. D. Foster,Leonard N. Owen,Michael J. Pringle J. Chem. Soc. Perkin Trans. 1 1973 2397
• 4. Selective protection of polyamines: synthesis of model compounds and spermidine derivatives
  M. Lurdes S. Almeida,Leif Grehn,Ulf Ragnarsson J. Chem. Soc. Perkin Trans. 1 1988 1905
• 5. Cellulose nanocrystal zero-valent iron nanocomposites for groundwater remediation
  Nathan Bossa,Alexis Wells Carpenter,Naresh Kumar,Charles-Fran?ois de Lannoy,Mark Wiesner Environ. Sci.: Nano 2017 4 1294

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Recent Advances in the Application of N-Methyl-1,4-phenylenediamine (CAS 623-09-6) in Chemical Biology and Pharmaceutical Research

N-Methyl-1,4-phenylenediamine (CAS 623-09-6) is a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Recent studies have highlighted its significance in the development of novel therapeutic agents, particularly in the fields of oncology and neurodegenerative diseases. This research brief aims to summarize the latest findings on the applications and mechanisms of N-Methyl-1,4-phenylenediamine, providing insights into its potential as a versatile building block in drug discovery and chemical biology.

One of the most notable advancements involves the use of N-Methyl-1,4-phenylenediamine in the synthesis of polyaniline-based nanomaterials. These materials have shown promise in drug delivery systems due to their biocompatibility and conductive properties. A 2023 study published in Advanced Materials demonstrated that nanoparticles functionalized with N-Methyl-1,4-phenylenediamine exhibited enhanced targeting efficiency and controlled release of anticancer drugs, such as doxorubicin, in vitro and in vivo.

In addition to its role in drug delivery, N-Methyl-1,4-phenylenediamine has been investigated as a precursor for the development of novel enzyme inhibitors. Researchers have utilized its structural features to design compounds that selectively target monoamine oxidase (MAO) enzymes, which are implicated in neurodegenerative disorders like Parkinson's disease. A recent paper in Journal of Medicinal Chemistry reported the synthesis of a series of MAO-B inhibitors derived from N-Methyl-1,4-phenylenediamine, showing significant neuroprotective effects in preclinical models.

Furthermore, the compound's redox properties have been exploited in the development of biosensors. A 2024 study in Analytical Chemistry described a novel electrochemical sensor based on N-Methyl-1,4-phenylenediamine for the detection of reactive oxygen species (ROS) in biological samples. This sensor demonstrated high sensitivity and selectivity, making it a valuable tool for monitoring oxidative stress in disease states.

Despite these promising applications, challenges remain in optimizing the stability and bioavailability of N-Methyl-1,4-phenylenediamine-derived compounds. Ongoing research is focused on modifying its chemical structure to improve pharmacokinetic properties while retaining its therapeutic efficacy. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinical applications.

In conclusion, N-Methyl-1,4-phenylenediamine (CAS 623-09-6) continues to be a molecule of significant interest in chemical biology and pharmaceutical research. Its diverse applications—from drug delivery to enzyme inhibition and biosensing—highlight its potential as a multifunctional agent. Future studies should explore its utility in combination therapies and personalized medicine approaches, leveraging its unique chemical properties for targeted interventions.

• 68442-68-2(Styrenated diphenylamine)
• 27215-51-6(Benzenediamine,N,N,N',N'-tetramethyl-)
• 50617-73-7(N1-Methylbenzene-1,3-diamine)
• 100-22-1(N,N,N',N'-Tetramethyl-p-phenylenediamine)
• 105-10-2(Alarmine)
• 2739-12-0(N-Methylaniline Hydrochloride)
• 101357-19-1(Benzenamine, N,N-dimethyl-, oxidized, molybdatetungstatephosphates)
• 101357-17-9(Benzenamine,N,N-dimethyl-, oxidized)
• 105597-82-8(1,4-Benzenediamine,N,N'-bis[4-[[4-[[4-(phenylamino)phenyl]amino]phenyl]amino]phenyl]-)
• 10541-30-7(N1,N4-dimethylbenzene-1,4-diamine dihydrochloride)